Business
MRES: Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing
MRES: Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing.
About this update from Institute Of Biomedical Research Corp.
[{"type":"text","content":"\n\n\n\nMRES: Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMRES: Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing\nPR Newswire\nCAPE TOWN, South Africa, July 5, 2023\n\n\n\nMRES:  Institute of Biomedical Research Announces Application for Name Change and\nNew Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing\nCAPE TOWN, South Africa, July 5, 2023 /PRNewswire/ --  Institute of Biomedical Research Corp. (OTC PINK: MRES) (\"Institute of Biomedical Research\" or the \"Company\"), a nutraceutical biotechnology company focused on alternative plant-based cannabinoids, medical psilocybin and mental health therapeutic research powered by artificial intelligence, and evidence-based sustainable products and solutions, is pleased to share the following update and corporate initiatives:\nThe Company has instructed its corporate lawyer of record, Matthew McMurdo, Esq. of McMurdo Law Group, LLC, New York, New York to start the process of Corporate Name Change and New Ticker Symbol, and to take all measures immediately to effectuate such.\nMRES intends to undergo a name change that better reflects the company's evolving business objectives and strategic direction. The new name will capture the essence of MRES's expansion plans and reinforce its commitment to delivering innovative solutions and sustainable growth in the biotechnology sector. Furthermore, MRES will adopt a new ticker symbol to coincide with its name change.\nJeff Robinson, CEO of Institute of Biomedical Research, expressed optimism about the future and the opportunities that lie ahead. \"We are excited to embark on this transformative journey, which we believe will position MRES as a formidable player in the biotechnology and phytomedicine sector. The name change and new ticker symbol will align our corporate busines...